A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis

On behalf of the Dupilumab Italian National Access Program (Dup-INAP group)

doi:10.1080/09546634.2020.1773379

A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis

On behalf of the Dupilumab Italian National Access Program (Dup-INAP group)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1146-1149
Journal	Journal of Dermatological Treatment
Volume	33
Issue number	2
DOIs	https://doi.org/10.1080/09546634.2020.1773379
Publication status	Published - 2022

ASJC Scopus subject areas

Dermatology

Access to Document

10.1080/09546634.2020.1773379

Cite this

@article{7d28be66c3f54ceabd5ec8b08961dce6,

title = "A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis",

author = "{On behalf of the Dupilumab Italian National Access Program (Dup-INAP group)} and Fargnoli, {M. C.} and M. Esposito and S. Ferrucci and G. Girolomoni and A. Offidani and A. Patrizi and K. Peris and A. Costanzo and G. Malara and G. Pellacani and M. Romanelli and P. Amerio and A. Cristaudo and Flori, {M. L.} and A. Motolese and P. Betto and C. Patruno and P. Pigatto and C. Peccianti and G. Stinco and I. Zalaudek and L. Bianchi and V. Boccaletti and Cannavo, {S. P.} and F. Cusano and S. Lembo and R. Mozzillo and R. Gallo and C. Potenza and F. Rongioletti and R. Tiberio and T. Grieco and G. Micali and S. Persechino and M. Pettinato and S. Pucci and L. Stingeni and C. Caruso and G. Argenziano",

year = "2022",

doi = "10.1080/09546634.2020.1773379",

language = "English",

volume = "33",

pages = "1146--1149",

journal = "Journal of Dermatological Treatment",

issn = "0954-6634",

publisher = "Informa Healthcare",

number = "2",

}

TY - JOUR

T1 - A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis

AU - On behalf of the Dupilumab Italian National Access Program (Dup-INAP group)

AU - Fargnoli, M. C.

AU - Esposito, M.

AU - Ferrucci, S.

AU - Girolomoni, G.

AU - Offidani, A.

AU - Patrizi, A.

AU - Peris, K.

AU - Costanzo, A.

AU - Malara, G.

AU - Pellacani, G.

AU - Romanelli, M.

AU - Amerio, P.

AU - Cristaudo, A.

AU - Flori, M. L.

AU - Motolese, A.

AU - Betto, P.

AU - Patruno, C.

AU - Pigatto, P.

AU - Peccianti, C.

AU - Stinco, G.

AU - Zalaudek, I.

AU - Bianchi, L.

AU - Boccaletti, V.

AU - Cannavo, S. P.

AU - Cusano, F.

AU - Lembo, S.

AU - Mozzillo, R.

AU - Gallo, R.

AU - Potenza, C.

AU - Rongioletti, F.

AU - Tiberio, R.

AU - Grieco, T.

AU - Micali, G.

AU - Persechino, S.

AU - Pettinato, M.

AU - Pucci, S.

AU - Stingeni, L.

AU - Caruso, C.

AU - Argenziano, G.

PY - 2022

Y1 - 2022

UR - http://www.scopus.com/inward/record.url?scp=85087613595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087613595&partnerID=8YFLogxK

U2 - 10.1080/09546634.2020.1773379

DO - 10.1080/09546634.2020.1773379

M3 - Letter

C2 - 32436765

AN - SCOPUS:85087613595

VL - 33

SP - 1146

EP - 1149

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

IS - 2

ER -

A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this